Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shen, Liangfang"'
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-11 (2021)
Cell Death Discovery
Cell Death Discovery
Radioresistance emerges as the major obstacle to nasopharyngeal carcinoma (NPC) treatment, further understanding of underlying mechanisms is necessary to overcome the radioresistance and improve the therapeutic effect. In this study, we first identif
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chen X; Department of Radiation Oncology, Cancer Hospital of the University of Chinese, Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China., Wang W; Gastroenterology and Urology Department II, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; Clinical Research Center for Gastrointestinal Cancer in Hunan Province, Changsha, China., Zou Q; Department of Medical Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China., Zhu X; Department of Radiation Oncology, Guangxi Medical University Affiliated Tumor Hospital & Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education & Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Nanning, China., Lin Q; Department of Radiation Oncology, Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China., Jiang Y; Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China., Sun Y; Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Shen L; Department of Oncology, Xiangya Hospital Central South University, Changsha, China., Wang L; Department of Medical Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China., Zou G; Department of Oncology, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China., Lin X; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, China., Lin S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China., Li M; Department of Radiation Therapy for Thoracic Tumors, Zhongshan City People's Hospital, Zhongshan, China., Wang Y; Tumor Radiotherapy Center, Chongqing University Cancer Hospital, Chongqing Cancer Hospital, Chongqing Cancer Institute, Chongqing, China., Xu R; Department of Oncology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China., Ao R; Oncology Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine UESTC, Chengdu, China., Wang R; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Lin H; Department of Medical Oncology, The Second Affiliated Hospital of Hainan Medica University, Haikou, China., Huang S; Department of Radiation Oncology, Cancer Hospital of the University of Chinese, Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China., Xu T; Department of Radiation Oncology, Fudan University, Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China., Li W; Akeso Biopharma Inc., Zhongshan, China., Xia M; Akeso Biopharma Inc., Zhongshan, China., Xia Y; Akeso Biopharma Inc., Zhongshan, China., Wang Z; Akeso Biopharma Inc., Zhongshan, China., Li B; Akeso Biopharma Inc., Zhongshan, China., Li J; Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, China. lijingao@hotmail.com.; NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital, Nanchang Medical College), Nanchang, China. lijingao@hotmail.com., Hu C; Department of Radiation Oncology, Fudan University, Shanghai Cancer Center, Shanghai, China. hucsu62@163.com.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. hucsu62@163.com.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China. hucsu62@163.com.
Publikováno v:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Jun 19; Vol. 9 (1), pp. 148. Date of Electronic Publication: 2024 Jun 19.
Autor:
Zhou P; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, China.; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China., Peng X; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, China.; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China., Tang S; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, China., Zhang K; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, China., Tan Z; Institute of Molecular Medicine and Oncology, College of Biology, Hunan University, Changsha, 410012, China., Li D; Institute of Molecular Medicine and Oncology, College of Biology, Hunan University, Changsha, 410012, China., Shen L; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, China., Peng J; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410078, China. jinwupeng2005@aliyun.com.; Department of Pathology, Xiangya Changde Hospital, Changde, 415000, China. jinwupeng2005@aliyun.com., Yang L; Department of Oncology, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, China. yanglifang@csu.edu.cn.; Cancer Research Institute, School of Basic Medicine Science, Central South University, Changsha, 410078, China. yanglifang@csu.edu.cn.; Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China. yanglifang@csu.edu.cn.
Publikováno v:
Oncogene [Oncogene] 2023 Apr; Vol. 42 (16), pp. 1308-1320. Date of Electronic Publication: 2023 Mar 07.
Autor:
Shen L; Department of Oncology, Xiangya Hospital, Central South University, No. 87, Xiangya Road, Kaifu District, Changsha, 410008, Hunan, People's Republic of China., Li Y; Department of Nursing, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China., Li N; Department of Oncology, Xiangya Hospital, Central South University, No. 87, Xiangya Road, Kaifu District, Changsha, 410008, Hunan, People's Republic of China., Zhao Y; Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China., Zhou Q; Department of Oncology, Xiangya Hospital, Central South University, No. 87, Xiangya Road, Kaifu District, Changsha, 410008, Hunan, People's Republic of China., Shen L; Department of Oncology, Xiangya Hospital, Central South University, No. 87, Xiangya Road, Kaifu District, Changsha, 410008, Hunan, People's Republic of China., Li Z; Department of Oncology, Xiangya Hospital, Central South University, No. 87, Xiangya Road, Kaifu District, Changsha, 410008, Hunan, People's Republic of China. lizhanzhan@csu.edu.cn.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China. lizhanzhan@csu.edu.cn.
Publikováno v:
Scientific reports [Sci Rep] 2022 Mar 16; Vol. 12 (1), pp. 4527. Date of Electronic Publication: 2022 Mar 16.
Autor:
Tong J; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA., Tan X; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, P.R. China., Risnik D; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA., Gao M; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA., Song X; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.; Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, P.R. China., Ermine K; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA., Shen L; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, P.R. China., Wang S; Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, 48109, USA., Yu J; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA., Zhang L; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA. zhanglx@upmc.edu.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA. zhanglx@upmc.edu.
Publikováno v:
Oncogene [Oncogene] 2021 Dec; Vol. 40 (48), pp. 6566-6578. Date of Electronic Publication: 2021 Oct 06.